Therapeutic Market of Narcolepsy in Seven Major Markets Shall Reach up to USD 2.4 Billion by 2027
According to new report estimation, the total prevalent population of Narcolepsy in 7 major markets was calculated to be 0.5 Million in 2016.
The United States accounts for the highest market size of Narcolepsy as compared to the EU5 countries (United Kingdom, France, Germany, Spain and Italy) and Japan. Report estimates suggest that the therapeutic market of Narcolepsy in seven major markets shall reach up to USD 2.4 Billion by 2027.
Overall, the increasing diagnosed prevalence of the disease along with the promising emerging pipeline therapies will fuel the market during the forecasted period of 2018-2027.
List of Companies | |
Pipeline Products | Marketed Products |
|
|
|
|
|
|
|
|
|
|
|
|